Cardiac Care FacilitiesHospital-Physician Joint VenturesQuebecCardiologyHeartCardiac Surgical ProceduresRetrospective StudiesTreatment OutcomeHeart RateNational Institutes of Health (U.S.)Kidney TransplantationHeart TransplantationAcademies and InstitutesTransplantsHeart FailureGraft RejectionGraft SurvivalInstitute of Medicine (U.S.)Immunosuppressive AgentsHeart DiseasesTransplantation, HomologousHeart Defects, CongenitalTissue DonorsTransplantationNational Heart, Lung, and Blood Institute (U.S.)National Cancer Institute (U.S.)Time FactorsLung TransplantationFetal HeartTissue and Organ ProcurementRisk FactorsBone Marrow TransplantationHeart ValvesUnited StatesPostoperative ComplicationsCyclosporineFollow-Up StudiesTacrolimusHeart AtriaWaiting ListsLiving DonorsImmunosuppressionProspective StudiesHematopoietic Stem Cell TransplantationNational Institute of Mental Health (U.S.)Heart BlockMyocardiumCytomegalovirus InfectionsFetal Tissue TransplantationNational Institute for Occupational Safety and Health (U.S.)Mycophenolic AcidHistocompatibility TestingKidney Failure, ChronicCadaverHeart Arrest, InducedHeart Function TestsTransplantation ImmunologyIncidenceSurvival RateImmunocompromised HostSurvival AnalysisHeart-Lung TransplantationPrognosisMyocardial ContractionCohort StudiesMyocardial IschemiaLiver FailureNational Institute of Allergy and Infectious Diseases (U.S.)Graft vs Host DiseaseCoronary DiseaseRisk AssessmentTransplantation, HeterotopicChronic Disease